HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ABA13

structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzimidazoles: 245
      - ABA13: 1

Experts

1.	Bailly, C: 1 article (11/2003)
2.	Baron, A: 1 article (11/2003)
3.	Higgins, C: 1 article (11/2003)
4.	Mann, J: 1 article (11/2003)
5.	Neidle, S: 1 article (11/2003)
6.	Seaton, A: 1 article (11/2003)
7.	van den Berg, H: 1 article (11/2003)

Related Diseases

1.

Breast Neoplasms (Breast Cancer)

11/01/2003 - "In this study, we have examined their cellular behaviour in detail and have shown that two of these compounds (ABA13 and ABA833) potently inhibit the proliferation of a range of human tumour cell lines, and show some specificity towards breast carcinoma cell lines. "
11/01/2003 - "Flow cytometric analysis revealed that ABA13 and ABA833 (50-500 nM) induced an S phase block and increased the pre-G1 population in MCF-7 and MDA 468 human breast cancer cells. "

Related Drugs and Biologics

1.	ABA833